Attached files
| file | filename |
|---|---|
| 8-K - Adynxx, Inc. | e606965_8k-hepalife.htm |
| EX-9.1 - Adynxx, Inc. | e606965_ex9-1.htm |
| EX-4.2 - Adynxx, Inc. | e606965_ex4-2.htm |
| EX-4.1 - Adynxx, Inc. | e606965_ex4-1.htm |
| EX-2.2 - Adynxx, Inc. | e606965_ex2-2.htm |
| EX-2.1 - Adynxx, Inc. | e606965_ex2-1.htm |
| EX-10.3 - Adynxx, Inc. | e606965_ex10-3.htm |
| EX-10.2 - Adynxx, Inc. | e606965_ex10-2.htm |
| EX-99.1 - Adynxx, Inc. | e606965_ex99-1.htm |
| EX-10.1 - Adynxx, Inc. | e606965_ex10-1.htm |
[Letterhead
of Peterson Sullivan LLP]
May 13,
2010
Securities
and Exchange Commission
100 F
Street N.E.
Washington,
DC 20549
Commissioners:
We have
read Item 4.01 of Form 8-K dated on or around May 17, 2010 of HepaLife
Technologies, Inc. and are in agreement with the statements contained therein
concerning our firm.
/s/
PETERSON SULLIVAN LLP